ARCHIVES

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Cancer Incidence Rates Climb In HIV-Positive Female Populations

April 27, 2012

AMA Supports Right To Silicone Implants, Kessler Takes Issues

December 3, 1993

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

September issue of Business & Regulatory Report included (8-page issue).

October 4, 2002